vs
Digimarc CORP（DMRC）与KORU Medical Systems, Inc.（KRMD）财务数据对比。点击上方公司名可切换其他公司
KORU Medical Systems, Inc.的季度营收约是Digimarc CORP的1.2倍（$10.9M vs $8.9M），KORU Medical Systems, Inc.同比增速更快（23.3% vs 2.9%），Digimarc CORP自由现金流更多（$895.0K vs $687.0K），过去两年KORU Medical Systems, Inc.的营收复合增速更高（15.3% vs -5.3%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
KORU医疗系统公司是一家专业医疗技术企业，主营设计、生产和销售创新型流动输液系统及配套一次性耗材，服务全球家庭护理、临床试验、急症护理领域的医疗机构与患者，专注于提升专科药物输送的安全性与舒适度。
DMRC vs KRMD — 直观对比
营收规模更大
KRMD
是对方的1.2倍
$8.9M
营收增速更快
KRMD
高出20.4%
2.9%
自由现金流更多
DMRC
多$208.0K
$687.0K
两年增速更快
KRMD
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $10.9M |
| 净利润 | $-4.2M | — |
| 毛利率 | 63.5% | 62.6% |
| 营业利润率 | -48.2% | -5.0% |
| 净利率 | -47.2% | — |
| 营收同比 | 2.9% | 23.3% |
| 净利润同比 | 51.4% | — |
| 每股收益（稀释后） | $-0.18 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCKRMD
| Q4 25 | $8.9M | $10.9M | ||
| Q3 25 | $7.6M | $10.4M | ||
| Q2 25 | $8.0M | $10.2M | ||
| Q1 25 | $9.4M | $9.6M | ||
| Q4 24 | $8.7M | $8.8M | ||
| Q3 24 | $9.4M | $8.2M | ||
| Q2 24 | $10.4M | $8.4M | ||
| Q1 24 | $9.9M | $8.2M |
净利润DMRCKRMD
| Q4 25 | $-4.2M | — | ||
| Q3 25 | $-8.2M | $-778.0K | ||
| Q2 25 | $-8.2M | $-206.9K | ||
| Q1 25 | $-11.7M | $-1.2M | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-10.8M | $-1.6M | ||
| Q2 24 | $-9.3M | $-988.7K | ||
| Q1 24 | $-10.3M | $-1.9M |
毛利率DMRCKRMD
| Q4 25 | 63.5% | 62.6% | ||
| Q3 25 | 58.3% | 60.2% | ||
| Q2 25 | 58.8% | 63.5% | ||
| Q1 25 | 65.0% | 62.8% | ||
| Q4 24 | 60.8% | 62.9% | ||
| Q3 24 | 62.4% | 63.4% | ||
| Q2 24 | 66.1% | 65.0% | ||
| Q1 24 | 62.5% | 62.3% |
营业利润率DMRCKRMD
| Q4 25 | -48.2% | -5.0% | ||
| Q3 25 | -109.7% | -8.3% | ||
| Q2 25 | -105.2% | -3.1% | ||
| Q1 25 | -128.9% | -12.9% | ||
| Q4 24 | -105.1% | -18.0% | ||
| Q3 24 | -120.4% | -20.8% | ||
| Q2 24 | -96.2% | -14.1% | ||
| Q1 24 | -109.2% | -23.9% |
净利率DMRCKRMD
| Q4 25 | -47.2% | — | ||
| Q3 25 | -106.9% | -7.5% | ||
| Q2 25 | -102.6% | -2.0% | ||
| Q1 25 | -125.2% | -12.1% | ||
| Q4 24 | -99.9% | — | ||
| Q3 24 | -113.9% | -19.3% | ||
| Q2 24 | -89.3% | -11.7% | ||
| Q1 24 | -104.0% | -23.6% |
每股收益（稀释后）DMRCKRMD
| Q4 25 | $-0.18 | $-0.11 | ||
| Q3 25 | $-0.38 | $0.02 | ||
| Q2 25 | $-0.38 | $0.00 | ||
| Q1 25 | $-0.55 | $0.03 | ||
| Q4 24 | $-0.40 | $-0.22 | ||
| Q3 24 | $-0.50 | $0.03 | ||
| Q2 24 | $-0.43 | $0.02 | ||
| Q1 24 | $-0.50 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $8.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $17.0M |
| 总资产 | $53.0M | $28.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCKRMD
| Q4 25 | $12.9M | $8.9M | ||
| Q3 25 | $12.6M | $8.5M | ||
| Q2 25 | $16.1M | $8.1M | ||
| Q1 25 | $21.6M | $8.7M | ||
| Q4 24 | $28.7M | $9.6M | ||
| Q3 24 | $33.7M | $8.8M | ||
| Q2 24 | $41.5M | $10.5M | ||
| Q1 24 | $48.9M | $10.8M |
股东权益DMRCKRMD
| Q4 25 | $40.2M | $17.0M | ||
| Q3 25 | $41.4M | $16.5M | ||
| Q2 25 | $46.5M | $16.5M | ||
| Q1 25 | $50.0M | $16.3M | ||
| Q4 24 | $61.4M | $16.8M | ||
| Q3 24 | $70.2M | $17.7M | ||
| Q2 24 | $77.2M | $18.7M | ||
| Q1 24 | $84.5M | $19.1M |
总资产DMRCKRMD
| Q4 25 | $53.0M | $28.2M | ||
| Q3 25 | $55.4M | $27.1M | ||
| Q2 25 | $60.7M | $25.5M | ||
| Q1 25 | $66.5M | $27.2M | ||
| Q4 24 | $75.8M | $27.2M | ||
| Q3 24 | $85.0M | $27.4M | ||
| Q2 24 | $93.4M | $27.3M | ||
| Q1 24 | $99.7M | $27.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $1.1M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | $687.0K |
| 自由现金流率自由现金流/营收 | 10.0% | 6.3% |
| 资本支出强度资本支出/营收 | 1.1% | 3.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | $-470.1K |
8季度趋势，按日历期对齐
经营现金流DMRCKRMD
| Q4 25 | $991.0K | $1.1M | ||
| Q3 25 | $-2.6M | $65.5K | ||
| Q2 25 | $-4.7M | $-460.3K | ||
| Q1 25 | $-5.5M | $-237.5K | ||
| Q4 24 | $-4.2M | $939.6K | ||
| Q3 24 | $-7.1M | $-923.9K | ||
| Q2 24 | $-6.8M | $11.3K | ||
| Q1 24 | $-8.4M | $-346.7K |
自由现金流DMRCKRMD
| Q4 25 | $895.0K | $687.0K | ||
| Q3 25 | $-2.8M | $13.0K | ||
| Q2 25 | $-4.9M | $-489.2K | ||
| Q1 25 | $-5.5M | $-680.9K | ||
| Q4 24 | $-4.2M | $896.0K | ||
| Q3 24 | $-7.2M | $-2.0M | ||
| Q2 24 | $-6.9M | $-112.9K | ||
| Q1 24 | $-8.5M | $-479.8K |
自由现金流率DMRCKRMD
| Q4 25 | 10.0% | 6.3% | ||
| Q3 25 | -36.9% | 0.1% | ||
| Q2 25 | -61.0% | -4.8% | ||
| Q1 25 | -59.1% | -7.1% | ||
| Q4 24 | -49.1% | 10.1% | ||
| Q3 24 | -75.7% | -24.5% | ||
| Q2 24 | -66.1% | -1.3% | ||
| Q1 24 | -85.8% | -5.9% |
资本支出强度DMRCKRMD
| Q4 25 | 1.1% | 3.7% | ||
| Q3 25 | 2.9% | 0.5% | ||
| Q2 25 | 2.5% | 0.3% | ||
| Q1 25 | 0.6% | 4.6% | ||
| Q4 24 | 0.2% | 0.5% | ||
| Q3 24 | 0.7% | 13.2% | ||
| Q2 24 | 0.3% | 1.5% | ||
| Q1 24 | 1.1% | 1.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
KRMD
| US | $8.3M | 76% |
| Non Us | $2.6M | 24% |
